CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Jul 13, 2026

Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
98.6%
-0.6% vs 52w high · +6.3% 1mo

Price (last ~year)

CVS Health Corp (CVS) reported Q1 2026 revenue of $100.43 billion and net income of $2.94 billion, with earnings per share of $2.57 exceeding analyst expectations. Shares are trading at $104.15, a 35.3% increase over the last three months that places the stock at 98.6% of its 52-week high. The company maintains a market capitalization of $132.89 billion against $78.34 billion in total debt and a Debt/EBITDA ratio of 5.1x.

Valuation

Market cap
$132.89B
P/E
45.68
PEG
0.293
P/B
1.716
P/S
0.328
EV/EBITDA
17.92
Beta
0.598
Analyst target
$108.81

Quality & returns

Gross margin
13.4%
Operating margin
4.1%
Profit margin
0.7%
ROE
3.8%
ROA
2.7%

Price movement

Last
$104.15
1-month
+6.3%
3-month
+35.3%
RSI (14)
67
vs SMA200
+27.8%
52-wk position
98.6% -0.6% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B
2025-06-30$98.92B$2.38B$1.02B$3.58B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots